Your browser doesn't support javascript.
loading
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
Gordon, Kenneth B; Duffin, Kristina Callis; Bissonnette, Robert; Prinz, Jörg C; Wasfi, Yasmine; Li, Shu; Shen, Yaung-Kaung; Szapary, Philippe; Randazzo, Bruce; Reich, Kristian.
Affiliation
  • Gordon KB; From the Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago (K.B.G.); the Department of Dermatology, University of Utah School of Medicine, Salt Lake City (K.C.D.); Innovaderm Research, Montreal (R.B.); the Department of Dermatology, Ludwig-Maximilians-Universität München, Munich (J.C.P.), and the Dermatologikum Hamburg, Hamburg (K.R.) - both in Germany; and Janssen Research and Development, Spring House (Y.W., S.L., Y.-K.S., P.S., B.R.), and the Department
N Engl J Med ; 373(2): 136-44, 2015 Jul 09.
Article in En | MEDLINE | ID: mdl-26154787
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Tumor Necrosis Factor-alpha / Interleukin-23 / Antibodies, Monoclonal, Humanized / Anti-Inflammatory Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2015 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Tumor Necrosis Factor-alpha / Interleukin-23 / Antibodies, Monoclonal, Humanized / Anti-Inflammatory Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 2015 Document type: Article Country of publication: United States